This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract
by Zacks Equity Research
AMN Healthcare's dismal results in the majority of its segments led to a soft overall third-quarter performance.
AMN Healthcare (AMN) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 5.17% and 2.60%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MultiPlan Corporation (MPLN) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
MultiPlan (MPLN) delivered earnings and revenue surprises of 21.94% and 0.18%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: AMN Healthcare Services (AMN) Q3 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN Stock Down Despite WorkWise Launch to Enhance Healthcare Delivery
by Zacks Equity Research
AMN Healthcare aims to enhance staffing efficiency and improve operational efficiency in healthcare systems via the latest launch.
Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio
by Zacks Equity Research
AMN shows growth potential with its broad services and high demand but faces challenges from industry regulations and strong competition in the staffing space.
Alignment Healthcare (ALHC) Moves 12.7% Higher: Will This Strength Last?
by Zacks Equity Research
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Is the Options Market Predicting a Spike in AMN Healthcare (AMN) Stock?
by Zacks Equity Research
Investors need to pay close attention to AMN Healthcare (AMN) stock based on the movements in the options market lately.
AMN Healthcare (AMN) Q2 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall second-quarter performance.
Compared to Estimates, AMN Healthcare (AMN) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 30.67% and 0.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Wall Street's Insights Into Key Metrics Ahead of AMN Healthcare (AMN) Q2 Earnings
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for AMN Healthcare (AMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
AMN Healthcare (AMN) Unveils ShiftWise Flex Manager Hub App
by Zacks Equity Research
AMN Healthcare's (AMN) Manager Hub app, part of the ShiftWise Flex platform, revolutionizes workforce management for healthcare organizations with enhanced mobile capabilities and comprehensive insights.
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: AMN Healthcare (AMN)
by Tracey Ryniec
When will travel nurse demand return?
New Strong Sell Stocks for June 26th
by Zacks Equity Research
AMN, ALNT and DNZOY have been added to the Zacks Rank #5 (Strong Sell) List on June 26, 2024.
New Strong Sell Stocks for June 4th
by Zacks Equity Research
AMN, ARCB and ARW have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2023.
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Compared to Estimates, AMN Healthcare (AMN) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMN Healthcare Services (AMN) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.30% and 0.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for AMN Healthcare (AMN) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of AMN Healthcare (AMN) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: AMN Healthcare Services (AMN) Q1 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.